Medtronic forays further into artificial intelligence
After diabetes, Medtronic is looking to leverage AI through a distribution agreement with Viz.ai, which uses the technology to streamline stroke care.
After diabetes, Medtronic is looking to leverage AI through a distribution agreement with Viz.ai, which uses the technology to streamline stroke care.
The company's latest growth push would put Bright in 22 markets across 13 states, including major metropolitan areas like Maricopa County in Arizona, Denver, Jacksonville, Tampa, Chicago, New York City and Cleveland.
The deadline for applications to the Pitch Perfect competition at INVEST Digital Health in Minneapolis is approaching. Our judges for the contest offered their perspective for what makes or breaks a healthcare startup's pitch.
NightWare's product learns the biometric pattern of a person's sleep and uses the wearable to intervene when a nightmare is detected, eventually adapting to a person's individual rhythms and sensitivities.
The two companies will collaborate to ensure timely cell collection, transport and delivery for autologous CAR-T cell therapies in cancers.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
For artificial intelligence to gain wider interest from clinicians, the way the algorithms arrive at their conclusions needs to be understandable.
TreeHouse Health has invested in 15 companies to date, representing different sectors of healthcare including health IT and services, medical device, and diagnostics.
Through their partnership, MyMeds users will be able to access medication-related educational content from Mayo Clinic.
Led by former UnitedHealthcare CEO Bob Sheehy, Bright is one of a crop of insurance startups looking to disrupt the industry with better consumer experiences and closer integrations with providers.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Ryan Johnson and Sten-Erik Hoidal, partners at the law firm Fredrikson & Byron, explained in an interview why the job of helping digital health startups navigate diverse state laws governing patient data privacy is set to become even more challenging.
Presbyterian Homes will acquire a 50 percent stake in Genevive from North Clinic. Allina will retain its existing 50 percent ownership interest in the organization.
Tom Wicka, the CEO and founder of NovuHealth, shared how his company was able to boost engagement from an incredibly difficult patient population at the Manova Summit in Minneapolis, Minnesota.
An entrepreneur panel at the Manova Summit in Minneapolis, Minnesota delved into the subject of how mental health digital therapeutics augment – instead of interrupt – the work of clinicians and care professionals.
Experts say proliferation of products makes standardization crucial, as ballooning complexity risks overwhelming apheresis centers and forcing service cuts.